Yea-Kang Yoo

Title: Yea-Kang Yoo: Innovator in Pharmaceutical Chemistry

Introduction

Yea-Kang Yoo is a prominent inventor based in Taejon-si, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications. His work focuses on creating innovative solutions for treating various health conditions.

Latest Patents

Yea-Kang Yoo holds a patent for "Pyrrolo [3,2-c] quinoline derivatives containing haloalkoxy group." This invention relates to a novel class of pyrrolo[3,2-c]quinoline derivatives, represented by Formula I, which includes their pharmaceutically acceptable salts. The patent outlines a process for preparing these compounds and their pharmaceutical compositions aimed at treating gastric ulcers. The specific haloalkoxy groups mentioned in the patent include trifluoromethoxy, difluoromethoxy, and trifluoroethoxy groups.

Career Highlights

Yea-Kang Yoo is affiliated with the Korea Research Institute of Chemical Technology, where he conducts research and development in chemical technology. His work has led to advancements in pharmaceutical formulations and therapeutic agents, showcasing his expertise in the field.

Collaborations

Yea-Kang Yoo has collaborated with notable colleagues, including Hyae-Gyeong Cheon and Hyo-Jung Kim. These partnerships have contributed to the success of his research projects and the development of innovative pharmaceutical solutions.

Conclusion

Yea-Kang Yoo is a distinguished inventor whose work in pharmaceutical chemistry has the potential to impact the treatment of gastric ulcers significantly. His innovative approach and dedication to research continue to drive advancements in the field.